For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and the formulated version represents a genuine breakthrough . These groundbreaking therapies stabilize the transthyretin protein, halting its harmful build-up and less